Antibiotic treatment modestly reduces protection against Mycobacterium tuberculosis reinfection in macaques
Infection and Immunity · 09.04.2024 · 92 (4)
DOI: 10.1128/iai.00535-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Immunity, erschienen am 09.04.2024. Verfasst von Sharie Keanne Ganchua und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Concomitant immunity is generally defined as an ongoing infection providing protection against reinfection . Its role in prevention of tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is supported by epidemiological evidence in humans as well as experimental evidence in mice and non-human primates (NHPs). Whether the presence of live Mtb, rather than simply persistent antigen, is necessary for concomitant immunity in TB is still unclear. Here, we investigated whether live Mtb plays a measurable role in control of secondary Mtb infection. Using cynomolgus macaques, molecularly barcoded Mtb libraries, positron emission tomography-computed tomography (PET CT) imaging, flow cytometry, and cytokine profiling, we evaluated the effect of antibiotic treatment after primary infection on immunological response and bacterial establishment, dissemination, and burden post-secondary infection. Our data provide evidence that, in this experimental model, treatment with antibiotics after primary infection reduced inflammation in the lung but was not associated with a significant change in bacterial establishment, dissemination, or burden in the lung or lymph nodes. Nonetheless, treatment of the prior infection with antibiotics did result in a modest reduction in protection against reinfection: none of the seven antibiotic-treated animals demonstrated sterilizing immunity against reinfection, while four of the seven non-treated macaques were completely protected against reinfection. These findings support that antibiotic-treated animals were still able to restrict bacterial establishment and dissemination after rechallenge compared to naïve macaques, but not to the full extent of non-antibiotic-treated macaques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA.
- Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Pauline Maiello, Sarah M Fortune, JoAnne L Flynn
Förderung
- NIAID NIH HHS
- HHS | National Institutes of Health
- Bill and Melinda Gates Foundation
Zitieren
APA
Ganchua, S. K., Maiello, P., Chao, M., Hopkins, F., Mugahid, D., Lin, P. L., Fortune, S. M., & Flynn, J. L. (2024). Antibiotic treatment modestly reduces protection against Mycobacterium tuberculosis reinfection in macaques. Infection and Immunity, 92(4). https://doi.org/10.1128/iai.00535-23
Vancouver
Ganchua SK, Maiello P, Chao M, Hopkins F, Mugahid D, Lin PL, et al. Antibiotic treatment modestly reduces protection against Mycobacterium tuberculosis reinfection in macaques. Infection and Immunity. 2024;92(4). doi:10.1128/iai.00535-23
BibTeX
@article{Ganchua2024,
author = {Ganchua, Sharie Keanne and Maiello, Pauline and Chao, Michael and Hopkins, Forrest and Mugahid, Douaa and Lin, Philana Ling and Fortune, Sarah M and Flynn, JoAnne L},
title = {Antibiotic treatment modestly reduces protection against Mycobacterium tuberculosis reinfection in macaques},
journal = {Infection and Immunity},
year = {2024},
volume = {92},
number = {4},
doi = {10.1128/iai.00535-23}
}
EUVIMED